Chemistree director Nico Zitelli provided this update; "Two major steps were taken in New Jersey last week that greatly increase our outlook in the Garden State. First, an Appellate Court upheld the disqualification of seven medical marijuana license applicants who had received a court injunction that stopped the Department of Health ("DOH") from reviewing all the applications received in the 2019 Request For Application ("RFA"), thus clearing the way for the DOH to once again begin the review process of the remaining 147 applications" CHM Consulting, LLC, d/b/a Applied Cannabis Sciences of New Jersey ("ACS"), currently has an application pending with the DOH for a vertically integrated license that will allow for the cultivation, manufacturing and processing, and retail sales of medical marijuana. After 18 months on pause, Chemistree has high hopes that ACS will be awarded licensure in this round considering the strong nature of our New Jersey team, operational history, and the municipal approvals already received within our operating jurisdictions. After finishing 20th out of 180 in the 2018 RFA, and with up to 24 new medical marijuana licenses being granted through this review process, the Company is hoping for positive news by the start of summer.
Chemistree Provides Corporate Update Regarding New Jersey Cannabis Legislation
New Jersey's Finest Kratom - Christopher's Organic Botanicals
Veriheal Other State Links
get your FL Office of Medical Marijuana Use card!
get your MD Medical Cannabis Commission card!